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The University of Tennessee (UT), the Oak Ridge
National Laboratory (ORNL), and the Kentucky Biome-
dical Research Infrastructure Network (KBRIN), have
collaborated over the past decade to share research and
educational expertise in bioinformatics. One result of
this collaboration is the joint sponsorship of an annual
regional summit to bring together researchers, educators
and students who are interested in bioinformatics from
a variety of research and educational institutions. This
summit provides unique opportunities for collaboration
and forging links between members of the various insti-
tutions. This year, the Tenth Annual UT-ORNL-KBRIN
Bioinformatics Summit was held at the University of
Memphis in Memphis, Tennessee from April 1-3, 2011.
A total of 225 participants pre-registered for the sum-
mit, with 146 from various Tennessee institutions and
60 from various Kentucky institutions. A number of
additional participants came from universities and
research institutions from other states and countries, e.
g. University of Arkansas Medical Sciences, University
of British Columbia, University of Cincinnati, Iowa State
University, etc. Seventy-four registrants were faculty,
with an additional 73 students, 50 staff, and 28 postdoc-
toral participants.
The conference program consisted of three days of
presentations. The first day included a pre-summit of
talks by researchers supported by the Kentucky Biome-
dical Research Infrastructure Network (KBRIN), and
three workshops covering the topics Next-Generation
Sequencing, the workflow platform Galaxy, and Gene-
MANIA. The next two days were dedicated to scientific
presentations divided into three plenary sessions on
Pediatric Genetics, Pharmacogenomics and Systems
Biology. Each session also included short talks selected
from the submitted poster abstracts.
Pre-summit KBRIN session
Dr. Eric Rouchka started the pre-summit KBRIN session
with an update on the supplement to the primary
KBRIN grant awarded in 2009. Thanks to the funding
provided by the supplement, five postdoctoral research
associates have been hired, along with two masters level
bioinformatics staff positions. In addition, a weekly
seminar series has been implemented that includes
externally invited speakers with strong research pro-
grams in bioinformatics.
Following was a series of short talks from various Uni-
versity of Louisville researchers: “Developing an Analysis
Pipeline for FT-ICR-MS Isotopologue Data from Stable
Isotope Resolved Metabolomics (SIRM) Experiments”
(Hunter Moseley), “Time Series Classifier Model for
miR-mRNA Relationships” (Jovan D. Rebolledo-Men-
dez), “Assessing Variations in NGS Data” (Alex Kem-
per), “A Systems Based Approach to Find Protein
Interactions Across Tissues” (Fahim Mohammad), “cate-
goryCompare: High-Throughput Data Meta-Analysis
Using Gene Annotations” (Robert M. Flight), “Colla-
borations between Biology/Bioinformatics” (Benjamin J.
Harrison).
Friday workshops
Jon Armstrong of Cofactor Genomics (St. Louis, MO;
http://www.cofactorgenomics.com) started the official
summit program with an excellent overview of the past,
present and future of DNA sequencing, beginning with
the Maxam-Gilbert [1] and Sanger [2] methods and
transitioning to the approaches used by next-generation
sequencers. Among the technologies covered were pyro-
sequencing [3], reversible dye terminator technology [4],
sequencing by ligation [5], and single molecule real time
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sequencing [6]. As Jon walked through each of the tech-
nologies, he also sought to explain what types of experi-
ments are best suited for each NGS platform, based on
the strengths and weaknesses of each technology. Given
the rapidly growing number of NGS machines available,
the information was extremely useful for both those
planning NGS experiments and those analyzing the
resulting data.
Following up, Dr. James Taylor from Emory University
gave a workshop on the workflow system GALAXY
[7,8]. Dr. Taylor started with a comprehensive explana-
tion of the many research issues motivating the develop-
ment of GALAXY as an easily modifiable, reproducible
workflow system for both biologists and bioinformati-
cians working with high-throughput data. He then pro-
ceeded to explain and demonstrate many of GALAXY’s
features by performing real world analyses using data
from the UCSC genome browser [9]. Notable features
include the ability to share workflows with others, the
ability to generate results pages (similar to full blown
publications) with workflows embedded in the docu-
ment and accessible to anyone viewing the page, and
the recent ability for NGS core lab implementations to
couple sample requests to workflows so that data pro-
cessing can occur as soon as the data becomes available.
As a final note, Dr. Taylor also demonstrated how easy
it is to set up GALAXY instances in Amazons EC2
cloud computing system, enabling one to take advantage
of cloud computing systems [10].
The final workshop was given by Dr. Quaid Morris
from the University of Toronto on the use of GeneMA-
NIA [11] for pathway and network analysis. GeneMA-
NIA uses gene association networks to assign probable
functions of genes based on guilt by association: those
genes that share connections (annotations or interac-
tions) probably share other attributes as well. GeneMA-
NIA is available either as a Cytoscape plugin [12,13] or
on the web.
Session I: pediatric genetics
The first session began with opening remarks by Dr.
Ramin Homayouni from the University of Memphis. Dr.
Homayouni provided a 10 year retrospective of the sum-
mit, its beginnings and growth, and the many collabora-
tions and new bioinformatic tools that have resulted
from those attending the conference.
The Pediatric Genetics session was truly underway
with Dr. Hakon Hakonarson of The Children’s Hospital
of Philadelphia discussing his research on determining
the genetic underpinnings of complex pediatric disor-
ders. As a way to try and cope with the large number of
rare genetic variants and their combinations that lead to
disease, his group at the Center for Applied Genomics
at Children’s Hospital of Philadelphia (CHOP) is
targeting to genotype 100,000 children over a five year
period making use of a biorepository. One of the goals
of this project is to link the genotypes to electronic
health care records for the purpose of tying together
genotype and phenotype information. Using this data,
they have determined SNPs involved in a number of dif-
ferent diseases, including juvenile (Type I) diabetes
[14-27], neuroblastoma [28-30] and autism spectrum
disorder [31-35]. They hope to be able to use this as a
retrospective tool to determine the causes of many
other diseases as well.
Following up on that, Dr. Jun Yang from St. Jude
Children’s Research Hospital presented work on phar-
macogenomics and racial disparities in childhood acute
lymphoblastic leukaemia [36]. Especially compelling was
the ability to use a set of genome wide SNPs to define
racial ancestry. These same SNPs also provided a large
amount of power in explaining a child’s probability of
survival of ALL. In addition to measuring the overall
survival probability, Dr. Yang discussed how this infor-
mation is being used to predict relapse and response to
five drugs: DNA, ASP, Chcb, AraC, and 6-TG.
Session II: pharmacogenomics
Starting the session on pharmacogenomics, Dr. Josh
Denny from Vanderbilt University presented work on
using electronic medical records for discovery and vali-
dation in genome science as part of the eMERGE Net-
work [37]. His group has concentrated on coupling
Vanderbilt’s opt-out biobank where samples are geno-
typed for high-value SNPs, with phenotypes generated
through text-mining of associated electronic medical
records. Specifically, Dr. Denny has interest in genotyp-
ing SNPs in 10,000 samples across 21 loci implicated in
atrial fibrulation, Crohn’s disease, type II diabetes, multi-
ple sclerosis, and rheumatoid arthritis. Highlighted chal-
lenges in using electronic medical records were
presented, included the diagnosis of diseases for which
treatment is covered by insurance but which the patient
did not have, and the use of templates in doctor’s offices
that result in non-informative field descriptions [38].
Both of these proved to be difficult for natural language
processing. Dr. Denny discussed case studies of using
the Vanderbilt Electronic Systems for Pharmacogenomic
Assessment (VESPA) to determine SNPs associated both
with disease and pharmacogenomic outcomes [39].
Dr. Ursula Amstutz of the University of British
Columbia presented work from the Canadian Pharmaco-
genomics Network for Drug Safety focusing on reducing
drug harm in children [40]. The current process of vali-
dating drug safety looks at evidence for drug efficacy
and safety at usual doses in populations; however physi-
cians treat individuals, who may have different reactions
to a given drug. When adverse drug effects in children
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are considered, the picture becomes more complicated,
due to differences in drug metabolism compared to
adults. Working with children who experience cisplatin
induced hearing loss, they were able to identify two
SNPs that predicted 48% of the cases of hearing loss
[41]. Another study examined anthracycline induced
cardiotoxicity, finding a highly significant SNP that was
validated in a separate group of patients [42]. It is
hoped that identification of these SNPs will lead to pre-
emptive testing to provide guidance in choosing meth-
ods of treatment for children.
Session III: systems biology
Quaid Morris from the University of Toronto led the
final plenary session with a talk titled “Three Degrees
of Propagation for Predicting Gene Function Using
Networks.” In this presentation, Dr. Morris discussed
the idea that biological interaction networks are in
general “small world” networks with a high degree of
hubs and short paths connecting most nodes. Using
the knowledge that often genes in the same pathway
are more likely to share neighbors than to be directly
connected, gene function can be better predicted from
functional gene and interaction networks by consider-
ing shared neighbors. Dr. Morris’ group observed that
in general, only three to four degrees of propagation
provides useful information when considering true
gene interactions. After that, every gene in a gene net-
work study is likely to be visited, much in the same
way that the idea of “six degrees of separation” is able
to link together any two different individuals world-
wide within six steps, on average, through “a friend of
a friend” relationships [43]. This is the process found
in the “Kevin Bacon game” in which participants are
challenged to link a random actor or actress to Kevin
Bacon in six or fewer steps where two actors/actresses
are connected if they appeared in a movie or commer-
cial together [44]. The Morris group has created a new
algorithmic approach, 3Prop, which takes this neigh-
borhood information into account to predict gene
function. 3Prop extends their previous work of predict-
ing gene function given limited annotation information
[11,45]. This approach has been applied to identify the
gender of users of social media sites by positively
weighting their friends’ genders and negatively weight-
ing their friends’ friends’ genders.
The second talk of the session was the final plenary
speaker, David Galas, from the Institute for Systems
Biology who presented “Genetics in the Age of Sequen-
cing: Converging on Complexity.” In this talk, Dr. Galas
discussed the transformation of human genetics as a
result of whole genome sequencing and associated com-
putational approaches. A discussion ensued about the
advances that genome wide association studies (GWAS)
have led into the understanding of complex diseases
[46] , including 1212 published genome-wide associa-
tions for 210 traits as of 12/2010 (http://www.genome.
gov/gwastudies). However, the point was made that
familial-based sequencing can be a powerful technology
for complex disease association, as demonstrated by a
family of four sequencing project in which two siblings
and their parents were sequenced [47]. Dr. Galas dis-
cussed the results of this project which was based on
two recessive Medalian disorders displayed in the sib-
lings: Miller syndrome and primary ciliary dyskinesia. By
looking at familial sequencing, the ability to detect
recombination events with high precision is possible,
which can lead to more directed analysis of disorders at
a genetic level. Dr. Galas expanded upon additional cur-
rent research at the Institute for Systems Biology,
including a multigenerational sequencing project and a
project to sequence 600 individuals (all in families)
focusing on diseases such as Huntington’s and congeni-
tal heart defects.
Posters and short talks
The poster session was held on day two before the main
banquet. Forty-eight posters were on display, all from a
variety of different research areas. A number of posters
were also selected for short talks in each session. The
talks and the presenting authors are listed below for
each session. For full author lists and abstracts see the
rest of the supplement.
Session I
“Contribution of common and rare variants in SLCO1B1
to variation in clearance of methotrexate in acute lym-
phoblastic leukemia patients” (Laura B. Ramsey, St. Jude
Children’s Research Hospital), “Significant Analysis of
Microarray Using Literature (SAMUL)” (Ramin
Homayouni, University of Memphis), “Integrating RNA-
Seq data Improves Protein Identification in Shotgun
Proteomics” (Xiaojing Wang, Vanderbilt University),
“The Challenges and Opportunities Facing us as we
Organize Genetic Research Data for “Meaningful Use"”
(Ted Kalbfleisch, Intrepid Bioinformatics).
Session II
“Integrative Biclustering of Heterogeneous Datasets
using a Bayesian Nonparametric Model with Application
to Chemogenomics” (Dazhuo Li, University of Louis-
ville), “A Statistical Procedure to Evaluate Agreement of
Differential Expression for Translational Cross-Species
Genomics” (Cuilan Gao, St. Jude Children’s Research
Hospital), “Utility of Methylation Biomarkers in Com-
plex Disease” (Gary L Rogers, University of Tennessee -
Knoxville), “Targeted Genotyping for Biomarker Devel-
opment” (Bradford Silver, Computable Genomix).
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Session III
“Identify the Key Genes and Pathways in the Progres-
sion of Hepatitis C Virus Induced Hepatocellular Carci-
noma Using a Systems Biology Approach” (Siyuan
Zheng, Vanderbilt University), “Bioinformatics Analysis
of Genome-Wide Differential Gene Expression Patterns
Associated with Differential Susceptibility to Severe
Group A Streptococcal Sepsis” (Nourtan Abdeltawab,
University of Tennessee Health Science Campus),
“Genes Without Borders: A Systematic Survey of Mobile
Genes and Genomes in Environmental Metagenomes”
(Ramy Aziz, San Diego State University), “Design,
Implementation and Uses of the Parabiclique Algo-
rithm” (Charles A. Phillips, University of Tennessee -
Knoxville).
Future plans
The 2012 Bioinformatics summit will return to the state
of Kentucky in the spring of 2012. Potential focus areas
include current technological trends in molecular biol-
ogy, applications of next-generation sequencing, and sys-
tems biology.
Acknowledgements
We would like to thank the additional Conference Program Committee
members Nigel Cooper (University of Louisville), Dan Goldowitz (University
of British Columbia), Julia Krushkal (University of Tennessee-Memphis), Mike
Langston (University of Tennessee-Knoxville), Terry Mark-Major (University of
Tennessee-Memphis), Cynthia Peterson (University of Tennessee-Knoxville),
Claire Rinehart (Western Kentucky University) Arnold Stromberg (University of
Kentucky), Rob Williams (University of Tennessee-Memphis) and Zhongming
Zhao (Vanderbilt University) for organizing an outstanding scientific
program. In addition, we wish to thank Stephanie Dearing, Terry Mark-Major,
Michelle Padgett, Donna Schulte and Jane Thornton for all of their efforts in
dealing with the conference organization details. Funding for the UT-ORNL-
KBRIN Summit is provided in part by the University of Memphis Office of the
Provost, Memphis Research Consortium, Kentucky Biomedical Research
Infrastructure Network (KBRIN), University of Tennessee Center for Integrative
and Translational Genomics, University of Tennessee Molecular Resource
Center, UT-ORNL Science Alliance, and NIH grant P20RR16481.
Author details
1Department of Computer Engineering and Computer Science, University of
Louisville, Duthie Center for Engineering, Louisville, KY 40292, USA.
2Department of Anatomical Sciences and Neurobiology, University of
Louisville, Louisville, KY 40292, USA. 3Department of Biological Sciences,
University of Memphis, Memphis, TN 38152, USA.
Published: 5 August 2011
References
1. Maxam AM, Gilbert W: A new method for sequencing DNA. Proc Natl
Acad Sci U S A 1977, 74:560-564.
2. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating
inhibitors. Proc Natl Acad Sci U S A 1977, 74:5463-5467.
3. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J,
Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV,
Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer ML,
Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM,
Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP,
Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT,
Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A,
Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF,
Rothberg JM: Genome sequencing in microfabricated high-density
picolitre reactors. Nature 2005, 437:376-380.
4. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J,
Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, Boutell JM, Bryant J,
Carter RJ, Keira CR, Cox AJ, Ellis DJ, Flatbush MR, Gormley NA, Humphray SJ,
Irving LJ, Karbelashvili MS, Kirk SM, Li H, Liu X, Maisinger KS, Murray LJ,
Obradovic B, Ost T, Parkinson ML, Pratt MR, Rasolonjatovo IM, Reed MT,
Rigatti R, Rodighiero C, Ross MT, Sabot A, Sankar SV, Scally A, Schroth GP,
Smith ME, Smith VP, Spiridou A, Torrance PE, Tzonev SS, Vermaas EH,
Walter K, Wu X, Zhang L, Alam MD, Anastasi C, Aniebo IC, Bailey DM,
Bancarz IR, Banerjee S, Barbour SG, Baybayan PA, Benoit VA, Benson KF,
Bevis C, Black PJ, Boodhun A, Brennan JS, Bridgham JA, Brown RC,
Brown AA, Buermann DH, Bundu AA, Burrows JC, Carter NP, Castillo N,
Chiara E Catenazzi, Chang S, Neil CR, Crake NR, Dada OO, Diakoumakos KD,
Dominguez-Fernandez B, Earnshaw DJ, Egbujor UC, Elmore DW, Etchin SS,
Ewan MR, Fedurco M, Fraser LJ, Fuentes Fajardo KV, Scott FW, George D,
Gietzen KJ, Goddard CP, Golda GS, Granieri PA, Green DE, Gustafson DL,
Hansen NF, Harnish K, Haudenschild CD, Heyer NI, Hims MM, Ho JT,
Horgan AM, Hoschler K, Hurwitz S, Ivanov DV, Johnson MQ, James T, Huw
Jones TA, Kang GD, Kerelska TH, Kersey AD, Khrebtukova I, Kindwall AP,
Kingsbury Z, Kokko-Gonzales PI, Kumar A, Laurent MA, Lawley CT, Lee SE,
Lee X, Liao AK, Loch JA, Lok M, Luo S, Mammen RM, Martin JW,
McCauley PG, McNitt P, Mehta P, Moon KW, Mullens JW, Newington T,
Ning Z, Ling NB, Novo SM, O’Neill MJ, Osborne MA, Osnowski A,
Ostadan O, Paraschos LL, Pickering L, Pike AC, Pike AC, Chris PD, Pliskin DP,
Podhasky J, Quijano VJ, Raczy C, Rae VH, Rawlings SR, Chiva RA, Roe PM,
Rogers J, Rogert Bacigalupo MC, Romanov N, Romieu A, Roth RK,
Rourke NJ, Ruediger ST, Rusman E, Sanches-Kuiper RM, Schenker MR,
Seoane JM, Shaw RJ, Shiver MK, Short SW, Sizto NL, Sluis JP, Smith MA,
Ernest Sohna SJ, Spence EJ, Stevens K, Sutton N, Szajkowski L, Tregidgo CL,
Turcatti G, Vandevondele S, Verhovsky Y, Virk SM, Wakelin S, Walcott GC,
Wang J, Worsley GJ, Yan J, Yau L, Zuerlein M, Rogers J, Mullikin JC,
Hurles ME, McCooke NJ, West JS, Oaks FL, Lundberg PL, Klenerman D,
Durbin R, Smith AJ: Accurate whole human genome sequencing using
reversible terminator chemistry. Nature 2008, 456:53-59.
5. Pandey V, Nutter RC, Prediger E: Applied Biosystems SOLiDTM System:
Ligation-Based Sequencing. In Next-Generation Genome Sequencing:
Towards Personalized Medicine.. 1 edition. Germany: Wiley-VCH;Janitz M.
Weinheim 2011:29-41.
6. Korlach J, Bjornson KP, Chaudhuri BP, Cicero RL, Flusberg BA, Gray JJ,
Holden D, Saxena R, Wegener J, Turner SW: Real-time DNA sequencing
from single polymerase molecules. Methods Enzymol 2010, 472:431-455.
7. Blankenberg D, Von KG, Coraor N, Ananda G, Lazarus R, Mangan M,
Nekrutenko A, Taylor J: Galaxy: a web-based genome analysis tool for
experimentalists. Curr Protoc Mol Biol 2010, Chapter 19:Unit-21.
8. Goecks J, Nekrutenko A, Taylor J: Galaxy: a comprehensive approach for
supporting accessible, reproducible, and transparent computational
research in the life sciences. Genome Biol 2010, 11:R86.
9. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM,
Haussler D: The human genome browser at UCSC. Genome Res 2002,
12:996-1006.
10. Afgan E, Baker D, Coraor N, Chapman B, Nekrutenko A, Taylor J: Galaxy
CloudMan: delivering cloud compute clusters. BMC Bioinformatics 2010,
11(Suppl 12):S4.
11. Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q: GeneMANIA: a
real-time multiple association network integration algorithm for
predicting gene function. Genome Biol 2008, 9(Suppl 1):S4.
12. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL, Morris Q,
Bader GD: GeneMANIA Cytoscape plugin: fast gene function predictions
on the desktop. Bioinformatics 2010, 26:2927-2928.
13. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N,
Schwikowski B, Ideker T: Cytoscape: a software environment for
integrated models of biomolecular interaction networks. Genome Res
2003, 13:2498-2504.
14. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA,
Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H,
Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS: Genome-wide
association study and meta-analysis find that over 40 loci affect risk of
type 1 diabetes. Nat Genet 2009, 41:703-707.
15. Glessner JT, Bradfield JP, Wang K, Takahashi N, Zhang H, Sleiman PM,
Mentch FD, Kim CE, Hou C, Thomas KA, Garris ML, Deliard S, Frackelton EC,
Rouchka et al. BMC Bioinformatics 2011, 12(Suppl 7):A1
http://www.biomedcentral.com/1471-2105/12/S7/A1
Page 4 of 6
Otieno FG, Zhao J, Chiavacci RM, Li M, Buxbaum JD, Berkowitz RI,
Hakonarson H, Grant SF: A genome-wide study reveals copy number
variants exclusive to childhood obesity cases. Am J Hum Genet 2010,
87:661-666.
16. Grant SF, Hakonarson H: Genome-wide association studies in type 1
diabetes. Curr Diab Rep 2009, 9:157-163.
17. Grant SF, Qu HQ, Bradfield JP, Marchand L, Kim CE, Glessner JT, Grabs R,
Taback SP, Frackelton EC, Eckert AW, Annaiah K, Lawson ML, Otieno FG,
Santa E, Shaner JL, Smith RM, Skraban R, Imielinski M, Chiavacci RM,
Grundmeier RW, Stanley CA, Kirsch SE, Waggott D, Paterson AD, Monos DS,
Polychronakos C, Hakonarson H: Follow-up analysis of genome-wide
association data identifies novel loci for type 1 diabetes. Diabetes 2009,
58:290-295.
18. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT,
Grabs R, Casalunovo T, Taback SP, Frackelton EC, Lawson ML, Robinson LJ,
Skraban R, Lu Y, Chiavacci RM, Stanley CA, Kirsch SE, Rappaport EF,
Orange JS, Monos DS, Devoto M, Qu HQ, Polychronakos C: A genome-
wide association study identifies KIAA0350 as a type 1 diabetes gene.
Nature 2007, 448:591-594.
19. Hakonarson H, Qu HQ, Bradfield JP, Marchand L, Kim CE, Glessner JT,
Grabs R, Casalunovo T, Taback SP, Frackelton EC, Eckert AW, Annaiah K,
Lawson ML, Otieno FG, Santa E, Shaner JL, Smith RM, Onyiah CC, Skraban R,
Chiavacci RM, Robinson LJ, Stanley CA, Kirsch SE, Devoto M, Monos DS,
Grant SF, Polychronakos C: A novel susceptibility locus for type 1
diabetes on Chr12q13 identified by a genome-wide association study.
Diabetes 2008, 57:1143-1146.
20. Hakonarson H, Grant SF: Genome-wide association studies in type 1
diabetes, inflammatory bowel disease and other immune-mediated
disorders. Semin Immunol 2009, 21:355-362.
21. Hilner JE, Perdue LH, Sides EG, Pierce JJ, Wagner AM, Aldrich A, Loth A,
Albret L, Wagenknecht LE, Nierras C, Akolkar B: Designing and
implementing sample and data collection for an international genetics
study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clin Trials 2010,
7:S5-S32.
22. Qu HQ, Grant SF, Bradfield JP, Kim C, Frackelton E, Hakonarson H,
Polychronakos C: Association analysis of type 2 diabetes Loci in type 1
diabetes. Diabetes 2008, 57:1983-1986.
23. Qu HQ, Grant SF, Bradfield JP, Kim C, Frackelton E, Hakonarson H,
Polychronakos C: Association of RASGRP1 with type 1 diabetes is
revealed by combined follow-up of two genome-wide studies. J Med
Genet 2009, 46:553-554.
24. Qu HQ, Bradfield JP, Grant SF, Hakonarson H, Polychronakos C: Remapping
the type I diabetes association of the CTLA4 locus. Genes Immun 2009,
10(Suppl 1):S27-S32.
25. Qu HQ, Bradfield JP, Belisle A, Grant SF, Hakonarson H, Polychronakos C:
The type I diabetes association of the IL2RA locus. Genes Immun 2009,
10(Suppl 1):S42-S48.
26. Wang K, Baldassano R, Zhang H, Qu HQ, Imielinski M, Kugathasan S,
Annese V, Dubinsky M, Rotter JI, Russell RK, Bradfield JP, Sleiman PM,
Glessner JT, Walters T, Hou C, Kim C, Frackelton EC, Garris M, Doran J,
Romano C, Catassi C, Van LJ, Guthery SL, Denson L, Piccoli D, Silverberg MS,
Stanley CA, Monos D, Wilson DC, Griffiths A, Grant SF, Satsangi J,
Polychronakos C, Hakonarson H: Comparative genetic analysis of
inflammatory bowel disease and type 1 diabetes implicates multiple loci
with opposite effects. Hum Mol Genet 2010, 19:2059-2067.
27. Wei Z, Wang K, Qu HQ, Zhang H, Bradfield J, Kim C, Frackleton E, Hou C,
Glessner JT, Chiavacci R, Stanley C, Monos D, Grant SF, Polychronakos C,
Hakonarson H: From disease association to risk assessment: an optimistic
view from genome-wide association studies on type 1 diabetes. PLoS
Genet 2009, 5:e1000678.
28. Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K,
Mosse YP, Wood A, Lynch JE, Pecor K, Diamond M, Winter C, Wang K,
Kim C, Geiger EA, McGrady PW, Blakemore AI, London WB, Shaikh TH,
Bradfield J, Grant SF, Li H, Devoto M, Rappaport ER, Hakonarson H,
Maris JM: Copy number variation at 1q21.1 associated with
neuroblastoma. Nature 2009, 459:987-991.
29. Nguyen LB, Diskin SJ, Capasso M, Wang K, Diamond MA, Glessner J, Kim C,
Attiyeh EF, Mosse YP, Cole K, Iolascon A, Devoto M, Hakonarson H, Li HK,
Maris JM: Phenotype Restricted Genome-Wide Association Study Using a
Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma
Susceptibility Loci. PLoS Genet 2011, 7:e1002026.
30. Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW,
Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M,
Wang Q, Glaberson W, Chiavacci R, Nguyen L, Jagannathan J, Saeki N,
Sasaki H, Grant SF, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M,
McGrady PW, London WB, Capasso M, Rahman N, Hakonarson H, Maris JM:
Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Nature 2011, 469:216-220.
31. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI,
Alvarez Retuerto AI, Imielinski M, Hadley D, Bradfield JP, Kim C, Gidaya NB,
Lindquist I, Hutman T, Sigman M, Kustanovich V, Lajonchere CM,
Singleton A, Kim J, Wassink TH, McMahon WM, Owley T, Sweeney JA,
Coon H, Nurnberger JI, Li M, Cantor RM, Minshew NJ, Sutcliffe JS, Cook EH,
Dawson G, Buxbaum JD, Grant SF, Schellenberg GD, Geschwind DH,
Hakonarson H: Genome-wide analyses of exonic copy number variants in
a family-based study point to novel autism susceptibility genes. PLoS
Genet 2009, 5:e1000536.
32. Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS, D’arcy M,
O’Hara RJ, Goldmuntz E, Grice DE, Shaikh TH, Hakonarson H, Buxbaum JD,
Elia J, White PS: Rare structural variation of synapse and
neurotransmission genes in autism. Mol Psychiatry 2011.
33. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J,
Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD,
Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolte S, Bolton PF,
Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J,
Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C,
Dawson G, de JM, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P,
Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C,
Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H,
Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C,
Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM,
Lamb JA, Laskawiec M, Leboyer M, Le CA, Leventhal BL, Lionel AC, Liu XQ,
Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C,
Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM,
Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF,
Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B,
Paton T, Pickles A, Pilorge M, Piven J, Ponting CP, Posey DJ, Poustka A,
Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K,
Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R,
Sequeira AF, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stein O,
Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K,
Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J,
Van EH, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH,
Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan BL,
Zurawiecki D, Zwaigenbaum L, Buxbaum JD, Cantor RM, Cook EH, Coon H,
Cuccaro ML, Devlin B, Ennis S, Gallagher L, Geschwind DH, Gill M, Haines JL,
Hallmayer J, Miller J, Monaco AP, Nurnberger JI Jr., Paterson AD, Pericak-
Vance MA, Schellenberg GD, Szatmari P, Vicente AM, Vieland VJ,
Wijsman EM, Scherer SW, Sutcliffe JS, Betancur C: Functional impact of
global rare copy number variation in autism spectrum disorders. Nature
2010, 466:368-372.
34. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D,
Imielinski M, Bradfield JP, Sleiman PM, Kim CE, Hou C, Frackelton E,
Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J,
Estes A, Korvatska O, Piven J, Sonnenblick LI, Alvarez Retuerto AI, Herman EI,
Dong H, Hutman T, Sigman M, Ozonoff S, Klin A, Owley T, Sweeney JA,
Brune CW, Cantor RM, Bernier R, Gilbert JR, Cuccaro ML, McMahon WM,
Miller J, State MW, Wassink TH, Coon H, Levy SE, Schultz RT, Nurnberger JI,
Haines JL, Sutcliffe JS, Cook EH, Minshew NJ, Buxbaum JD, Dawson G,
Grant SF, Geschwind DH, Pericak-Vance MA, Schellenberg GD,
Hakonarson H: Common genetic variants on 5p14.1 associate with
autism spectrum disorders. Nature 2009, 459:528-533.
35. Wang LS, Hranilovic D, Wang K, Lindquist IE, Yurcaba L, Petkovic ZB,
Gidaya N, Jernej B, Hakonarson H, Bucan M: Population-based study of
genetic variation in individuals with autism spectrum disorders from
Croatia. BMC Med Genet 2010, 11:134.
36. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G,
Cox NJ, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Willman CL,
Bowman WP, Camitta BM, Carroll A, Reaman GH, Carroll WL, Loh M,
Hunger SP, Pui CH, Evans WE, Relling MV: Ancestry and
pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat
Genet 2011, 43:237-241.
Rouchka et al. BMC Bioinformatics 2011, 12(Suppl 7):A1
http://www.biomedcentral.com/1471-2105/12/S7/A1
Page 5 of 6
37. McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R,
Masys DR, Ritchie MD, Roden DM, Struewing JP, Wolf WA: The eMERGE
Network: a consortium of biorepositories linked to electronic medical
records data for conducting genomic studies. BMC Med Genomics 2011,
4:13.
38. Rosenbloom ST, Denny JC, Xu H, Lorenzi N, Stead WW, Johnson KB: Data
from clinical notes: a perspective on the tension between structure and
flexible documentation. J Am Med Inform Assoc 2011, 18:181-186.
39. Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM, McCarty CA, Davis RL,
Skaar T, Lamba J, Savova G: The emerging role of electronic medical
records in pharmacogenomics. Clin Pharmacol Ther 2011, 89:379-386.
40. Ross CJ, Visscher H, Sistonen J, Brunham LR, Pussegoda K, Loo TT,
Rieder MJ, Koren G, Carleton BC, Hayden MR: The Canadian
Pharmacogenomics Network for Drug Safety: a model for safety
pharmacology. Thyroid 2010, 20:681-687.
41. Dionne F, Mitton C, Rassekh R, Brooks B, Ross C, Hayden M, Carleton B:
Economic impact of a genetic test for cisplatin-induced ototoxicity.
Pharmacogenomics J 2011.
42. Visscher H, Amstutz U, Sistonen J, Ross CJ, Hayden MR, Carleton BC:
Pharmacogenomics of cardiovascular drugs and adverse effects in
paediatrics. J Cardiovasc Pharmacol 2011.
43. Newman M, Barabasi A-L, Watts DJ: The Structure and Dynamics of
Networks. Princeton, NJ: Princeton University Press; 2006.
44. Fass C, Turtle B, Ginelli M: Six Degrees of Kevin Bacon. Plume Books; 1996.
45. Mostafavi S, Morris Q: Fast integration of heterogeneous data sources for
predicting gene function with limited annotation. Bioinformatics 2010,
26:1759-1765.
46. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS,
Manolio TA: Potential etiologic and functional implications of genome-
wide association loci for human diseases and traits. Proc Natl Acad Sci U
S A 2009, 106:9362-9367.
47. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen L,
Pant KP, Goodman N, Bamshad M, Shendure J, Drmanac R, Jorde LB,
Hood L, Galas DJ: Analysis of genetic inheritance in a family quartet by
whole-genome sequencing. Science 2010, 328:636-639.
doi:10.1186/1471-2105-12-S7-A1
Cite this article as: Rouchka et al.: Proceedings of the Tenth Annual UT-
ORNL-KBRIN Bioinformatics Summit 2011. BMC Bioinformatics 2011 12
(Suppl 7):A1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Rouchka et al. BMC Bioinformatics 2011, 12(Suppl 7):A1
http://www.biomedcentral.com/1471-2105/12/S7/A1
Page 6 of 6
